Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

aXichem

1.54 SEK-6.38 %20/11 17:25
Less than 1K followers

AXIC A

First North Stockholm

Chemicals

Basic Materials

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-6.38 %
-20.00 %
-46.90 %
+3.01 %
-25.06 %
-36.68 %
-86.10 %
-93.36 %
-90.81 %

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.

Read more
Market cap
117.57M SEK
Turnover
11.38K SEK
Revenue
18.45M
EBIT %
-94.8 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
26/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Third party research2026-10-15 11:18

aXichem: aXivite-order i ny distributionskanal - VH Corp

* Order om 1,2 MSEK via nätverksförsäljning i USA * Tre frågor till vd Torsten Helsing * Vi behåller vårt motiverade värde om 3,39 SEK per aktie aXichem meddelade nyligen att bolaget erhållit en order om 1,2 MSEK avseende kosttillskottsingrediensen aXivite...

aXichem
Press release2026-10-15 10:05

Västra Hamnen Market Focus: aXichem: aXivite-order i ny distributionskanal

aXichem
Press release2026-10-14 08:30

aXichem AB: aXichem receives order for aXivite[®] of SEK 1.2 million from a U.S. multi-level marketing company

aXichem

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release2026-10-14 08:30

aXichem AB: aXichem erhåller order för aXivite[®] värd 1,2 miljoner kronor från ett multi-level-marketing-företag i USA

aXichem
Regulatory press release2026-09-23 10:30

aXichem AB (publ) genomför en riktad emission i samband med utnyttjande av teckningsoptioner av serie TO2A

aXichem
Regulatory press release2026-09-23 10:30

aXichem AB (publ) carries out a directed share issue in connection with the exercise of warrants of series TO2A

aXichem
Regulatory press release2026-09-21 13:00

aXichem AB: aXichem announces the outcome of the exercise of the warrants of series TO2A

aXichem
Regulatory press release2026-09-21 13:00

aXichem AB: aXichem meddelar utfallet från utnyttjandet av teckningsoptioner av serie TO2A

aXichem
Regulatory press release2026-09-11 17:45

aXichem AB: aXichem enters into agreements on non-compensated subscription undertakings totaling approximately SEK 2.6 million regarding ongoing redemption of warrants of series TO2A

aXichem
Regulatory press release2026-09-11 17:45

aXichem AB: aXichem ingår avtal om vederlagsfria teckningsåtaganden om totalt cirka 2,6 MSEK avseende pågående inlösen av teckningsoptioner av serie TO2A

aXichem
Press release2026-09-08 08:30

aXichem AB: aXichem ser växande kommersiell användning i Brasilien för aXiphen[® ]ruminant då Garra Nutrição ökar volymen till fyra ton

aXichem
Press release2026-09-08 08:30

aXichem AB: aXichem notes growing commercial adoption in Brazil for aXiphen[®] ruminant as Garra Nutrição increases volume to four tonnes

aXichem
Regulatory press release2026-09-04 18:30

aXichem announces subscription price for TO2A, which can be exercised during the period 7 - 18 September 2026

aXichem
Regulatory press release2026-09-04 18:30

aXichem meddelar teckningskurs för TO2A, som kan nyttjas under perioden 7 - 18 september 2026

aXichem
Press release2026-09-02 15:00

Västra Hamnen Market Focus: aXichem on aXiphen in Europe

aXichem
Press release2026-08-31 14:00

aXichem meddelar: Tecnobeef i Brasilien tar ytterligare tre ton aXiphen[® ]ruminant

aXichem
Press release2026-08-31 14:00

aXichem announces: Tecnobeef in Brazil takes a further three tonnes of aXiphen[®] ruminant

aXichem
Third party research2026-08-31 09:35

aXichem: Milstolpe uppnådd, lansering i sikte - VH Corp

* Positivt vetenskapligt utlåtande från EFSA * Chr. Olesen fyllde avropsordern i Brasilien * Vi höjer vårt motiverade värde till 3,39 (3,07) SEK per aktie aXichem redovisade en omsättning om 4 MSEK och ett rörelseresultat om -4,3 MSEK för det andra kvartalet...

aXichem
Press release2026-08-31 09:30

Västra Hamnen Market Focus: aXichem: Milstolpe uppnådd, lansering i sikte

aXichem
Press release2026-08-28 08:00

Västra Hamnen Market Focus: aXichem presenterar Q2 2026

aXichem